勘误：心血管疾病的靶向治疗：精准治疗时代。
Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era.
作者信息
Xu Mengda, Zhang Kailun, Song Jiangping
机构信息
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
出版信息
Front Pharmacol. 2023 Feb 3;14:1145460. doi: 10.3389/fphar.2023.1145460. eCollection 2023.
Abstract
[This corrects the article DOI: 10.3389/fphar.2021.623674.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fphar.2021.623674。]
相似文献
1
Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era.
Front Pharmacol. 2023 Feb 3;14:1145460. doi: 10.3389/fphar.2023.1145460. eCollection 2023.
2
Corrigendum: Precision medicine: a new era for inner ear diseases.
Front Pharmacol. 2024 Feb 27;15:1385698. doi: 10.3389/fphar.2024.1385698. eCollection 2024.
3
Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era.
Front Pharmacol. 2021 Apr 16;12:623674. doi: 10.3389/fphar.2021.623674. eCollection 2021.
4
Corrigendum: Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine.
Front Pharmacol. 2020 Dec 4;11:614445. doi: 10.3389/fphar.2020.614445. eCollection 2020.
5
Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy.
Front Pharmacol. 2023 Jan 11;13:1123542. doi: 10.3389/fphar.2022.1123542. eCollection 2022.
6
Corrigendum: Docetaxel-loaded novel nano-platform for synergistic therapy of non-small cell lung cancer.
Front Pharmacol. 2022 Sep 7;13:964540. doi: 10.3389/fphar.2022.964540. eCollection 2022.
7
Corrigendum: Ion Channel Targeted Mechanisms of Anti-arrhythmic Chinese Herbal Medicine Xin Su Ning.
Front Pharmacol. 2019 May 9;10:493. doi: 10.3389/fphar.2019.00493. eCollection 2019.
8
Corrigendum: An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection.
Front Pharmacol. 2020 Feb 27;11:201. doi: 10.3389/fphar.2020.00201. eCollection 2020.
9
Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice.
Front Pharmacol. 2022 Jan 3;12:827490. doi: 10.3389/fphar.2021.827490. eCollection 2021.
10
Corrigendum: Advances in the roles of glycyrrhizic acid in cancer therapy.
Front Pharmacol. 2023 Dec 14;14:1345663. doi: 10.3389/fphar.2023.1345663. eCollection 2023.
引用本文的文献
1
Current Trends in Nanotheranostics: A Concise Review on Bioimaging and Smart Wearable Technology.
Nanotheranostics. 2023 Mar 11;7(3):258-269. doi: 10.7150/ntno.82886. eCollection 2023.
Zotero 插件